Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria
Clinical trial NCT03328897 · COMPLETED
Trial details
- NCT number
- NCT03328897
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-26
- Primary completion
- 2019-07-23
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.